The FINANCIAL — Alcon, one of the global leaders in eye care and a division of Novartis, has received US Food and Drug Administration (FDA) approval for its AcrySof IQ Aspheric IOL with the ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Alcon’s Unity combined vitreoretinal cataract system and stand-alone ...

Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology will be expanded globally, improving the efficiency of ...

Shares of eye care company Alcon AG (NYSE:ALC) are trading higher on Monday. The company has agreed to acquire LENSAR Inc (NASDAQ:LNSR), a firm recognized for its laser solutions in cataract surgery.

Alcon, the multinational pharmaceuticals company specializing in eye care, has agreed a deal to acquire cataract laser surgery pioneer Lensar. The deal, valued at up to $430 million, will expand Alcon ...

The first of two public debuts of eye-device companies with Orange County ties came last week when Alcon Inc. completed a $2.3 billion initial public offering on the New York Stock Exchange. Alcon, ...

Swiss eyecare giant Alcon has agreed to pay rival Johnson & Johnson (J&J) $199 million as part of a legal settlement surrounding the use of femtosecond lasers in cataract surgery. The ...

Aging is a natural part of life, and as we grow older, our bodies go through various changes. Our hair turns gray, our joints ache a bit more and our energy levels fluctuate. But one aspect of aging ...